[Skip to Navigation]
Sign In
Comment & Response
September 2018

Age and Treatment of Nonmelanoma Skin Cancer

Author Affiliations
  • 1Department of Dermatology, Baylor Scott & White Health, Texas A&M Health Science Center College of Medicine, Temple
JAMA Surg. 2018;153(9):866-867. doi:10.1001/jamasurg.2018.1676

To the Editor We read with great interest the research letter from Chauhan et al1 regarding the topic of surgical intervention in facial nonmelanoma skin cancer (fNMSC). The authors propose that age older than 90 years should be a relative contraindication for the treatment of fNMSC based on (1) the percentage of no residual carcinoma following excision (35.3% in the study) and (2) patient longevity. We agree these claims warrant further discussion; however, several points need clarification.

Add or change institution